AI Article Synopsis

Article Abstract

Objective: To evaluate pharmaceutical services in public hospital pharmacies of  the Federal District Health Department - Brazil (Secretaria de Saúde do Distrito  Federal, SES-DF).

Method: A cross-sectional evaluative study involving the 15 public hospitals under the SES-DF management. Hospitals were characterized and classified into four hierarchical strata. The pharmaceutical services related  to programming (quantity of medication to order), acquisition, storage,  distribution, management, selection, information, pharmacotechnical  component, pharmacotherapy follow-up, teaching and research were evaluated  using validated indicators. Next, algorithms were applied and the approximation percentages of service compliance were calculated, then  correlated to variables that could influence their results through linear regression analysis.

Results: Only four hospital pharmacies presented good compliance with the  evaluated services, three of them belonging to less complex hospitals. Only the  storage and management services presented good performance. The variables  that most influenced the performance of the services were managerial aspects  related to pharmacists and non pharmacists' workload per bed, the existence of  a program for human resources qualification, planning goals and targets and a  manual of norms and procedures, as well as professional qualification and  adequacy of the area in which the services were performed (p < 0.01).

Conclusions: The evaluated hospital pharmacies had average performance for  services compared to the ideal and better performance in logistics activities.  Pharmaceutical services require constant evaluation for rational interventions  that increase the proportion of executed health care activities and local  management capacity to make such actions more effective, efficient, qualified  and safe in the context of the SES-DF hospital network.

Download full-text PDF

Source
http://dx.doi.org/10.7399/fh.10941DOI Listing

Publication Analysis

Top Keywords

pharmaceutical services
16
hospital pharmacies
12
services
8
services public
8
public hospital
8
federal district
8
presented good
8
evaluation pharmaceutical
4
hospital
4
pharmacies federal
4

Similar Publications

Background: Adverse medicine events (AMEs) are unintended effects that occur following administration of medicines. Up to 70% of AMEs are not reported to, and hence remain undetected by, health care professionals and only 6% of AMEs are reported to regulators. Increased reporting by consumers, health care professionals, and pharmaceutical companies to medicine regulatory authorities is needed to increase the safety of medicines.

View Article and Find Full Text PDF

The aim of the study was to assess the comprehensiveness of the Reproductive Endocrinology and Infertility (REI) fellowship program websites in North America. All active REI fellowship program websites in the United States of America (USA) and Canada were evaluated and assessed using 72-point scoring criteria. Any fellowship programs without publicly accessible websites were excluded.

View Article and Find Full Text PDF

Bridging gaps in medication therapy management at community health centers: A mixed-methods study on patient perceptions and pharmacists' preparedness.

Explor Res Clin Soc Pharm

March 2025

Department of Pharmacology and Therapeutics, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Background: The primary goals of Medication Therapy Management (MTM) are to avoid pharmaceutical mistakes, facilitate accessible therapy, and encourage patients to actively participate in their health management.

Objectives: This study aimed to determine patients' perceptions of MTM services, evaluate the knowledge, attitudes, and practices (KAP) of Community Health Center (CHC) pharmacists regarding MTM services, and develop strategies to improve MTM services in CHCs.

Methods: A mixed-method approach was designed in three parts.

View Article and Find Full Text PDF

Introduction: Masking is a reporting bias where drug safety signals are muffled by elevated reporting of other medications in spontaneous reporting databases. While the impact of masking is often limited, its effect when using restricted designs, such as active comparators, can be consequential.

Methods: We used data from the US Food and Drugs Administration Adverse Event Reporting System (1999Q3-2013Q3) to study masking in a real-world example.

View Article and Find Full Text PDF

Objective: This study aims to analyze adverse drug events (ADE) related to romosozumab from the second quarter of 2019 to the third quarter of 2023 from FAERS database.

Methods: The ADE data related to romosozumab from 2019 Q2 to 2023 Q3 were collected. After data normalization, four signal strength quantification algorithms were used: ROR (Reporting Odds Ratios), PRR (Proportional Reporting Ratios), BCPNN (Bayesian Confidence Propagation Neural Network), and EBGM (Empirical Bayesian Geometric Mean).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!